Literature DB >> 20520968

Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori.

Erika Kague1, Cristiane Melissa Thomazini, Maria Inês de Campo Moura Pardini, Fabrício de Carvalho, Celso Vieira Leite, Nídia Alice Pinheiro.   

Abstract

CONTEXT: Gastric cancer is one of the top list of cancer types that most leads to death in Brazil and worldwide. Helicobacter pylori(H. pylori) is a class I carcinogen and infect almost 90% of chronic gastritis patients. Some genotypes confer different virulent potential to H. pylori and can increase the risk of gastritis development. Methylation of CpG islands can inactivate tumor suppressor genes and therefore, it can be involved in the tumorigenic process. CDH1 is a tumor suppressor gene that encodes the E-cadherin protein, which is important in maintaining cell-cell contacts. The inactivation of this gene can increase the chance of metastasis. Promoter methylation of CDH1 at early steps of gastric carcinogenesis is not yet completely understood.
OBJECTIVE: In this study, we investigated the methylation status of CDH1 in chronic gastritis samples and correlated it with the presence of H. pylori.
METHODS: Sixty gastric mucosal biopsies were used in this study. The detection of H. pylori was performed with the PCR primers specific to urease C gene. H. pylori genotyping was performed by PCR to cagA and vacA (s and m region). The methylation status of these gene CDH1 was analyzed using methylation-specific polymerase chain reaction and direct sequencing of the PCR products was performed using primers methylated and unmethylated in both forward and reverse directions.
RESULTS: H. pylori was detected in 90% of chronic gastritis samples; among these 33% were cagA positive and 100% vacA s1. The genotype vacA s2/m1 was not detected in any sample analyzed. Methylation of CDH1 was detected in 63.3% of chronic gastritis samples and 95% of them were also H. pylori-positive.
CONCLUSION: This work suggests that CDH1 gene methylation and H. pylori infection are frequent events in samples from Brazilian patients with chronic gastritis and reinforces the correlation between H. pylori infection and CDH1 inactivation in early steps of gastric tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20520968     DOI: 10.1590/s0004-28032010000100002

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  6 in total

Review 1.  Multifactorial etiology of gastric cancer.

Authors:  Jovanny Zabaleta
Journal:  Methods Mol Biol       Date:  2012

2.  CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer.

Authors:  Qi-Ming Yu; Xin-Bao Wang; Jun Luo; Shi Wang; Xian-Hua Fang; Jiang-Liu Yu; Zhi-Qiang Ling
Journal:  J Surg Oncol       Date:  2012-04-18       Impact factor: 3.454

Review 3.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

4.  Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism.

Authors:  Rongrong Zhao; Zhengxia Liu; Wenting Xu; Le Song; Haifeng Ren; Yang Ou; Yakun Liu; Siying Wang
Journal:  Cancer Med       Date:  2020-02-04       Impact factor: 4.452

5.  PCR-Based Detection and Genotyping of Helicobacter pylori in Endoscopic Biopsy Samples from Brazilian Patients.

Authors:  Silvia M Ferreira Menoni; Sandra Helena Alves Bonon; José Murilo Robilota Zeitune; Sandra Cecília Botelho Costa
Journal:  Gastroenterol Res Pract       Date:  2013-01-16       Impact factor: 2.260

Review 6.  The E-Cadherin Cleavage Associated to Pathogenic Bacteria Infections Can Favor Bacterial Invasion and Transmigration, Dysregulation of the Immune Response and Cancer Induction in Humans.

Authors:  Christian A Devaux; Soraya Mezouar; Jean-Louis Mege
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.